Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties
- 1 April 1989
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 139 (1) , 157-166
- https://doi.org/10.1002/jcp.1041390122
Abstract
Cyclic adenosine monophosphate (AMP) has numerous important effects on cell structure and function, but its role in endothelial cells is unclear. Since cyclic AMP has been shown to affect transmembrane transport, cell growth and morphology, cellular adhesion, and cytoskeletal organization, it may be an important determinant of endotelial barrier properties. To test this we exposed bovine pulmonary artery endothelial cell monolayers to substances known to increase cyclic AMP and measured their effect on endothelial permeability to albumin and endothelial cell cyclic AMP concentrations. Cholera toxin (CT), a stimulant of the guanine nucleotide binding subunit of adenylate cyclase, led to a concentration-dependent 2-6-told increase in cyclic AMP which was associated with a 3–10-fold reduction in albumin transfer across endothelial monolayers. The effect was not specific to albumin as similar barrier-enhancing effects were also noted with an unrelated macromolecule, fluorescein isothiocyanate (FITC)-dextran (MW 70,000). Barrier enhancement with cyclic AMP elevation was also observed with forskolin, a stimulant of the catalytic subunit of adenylate cyclase. The temporal pattern of barrier enhancement seen with these agents paralleled their effects on increasing cyclic AMP, and the barrier enhancement could be reproduced by incubation with either dibutyryl cyclic AMP or Sp-cAMPS, cyclic AMP-dependent protein kinase agonists. Furthermore, the forsko-lin effect on barrier enhancement was partially reversed with Rp-cAMPS, an antagonist of cyclic AMP-dependent protein kinase. Since endothelial actin polymerization may be an important determinant of endothelial barrier function, we sought to determine whether the cyclic AMP-induced effects were associated with increases in the polymerized actin pool (F-actin). Both cholera toxin and forskolin led to apparent endothelial cell spreading and quantitative increases in endothelial cell F-actin fluorescence. In conclusion, increased endothelial cell cyclic adenine nucleotide activity was an important determinant of endothelial barrier function in vitro. The barrier enhancement was associated with increased endothelial apposition and increases in F-actin, suggesting that influences on cytoskeletal assembly may be involved in this process.This publication has 39 references indexed in Scilit:
- Phalloidin enhances endothelial barrier function and reduces inflammatory permeability in vitroMicrovascular Research, 1988
- Regulation of adenylate cyclase by hormones and G‐proteinsFEBS Letters, 1987
- Histamine type I receptor occupancy increases endothelial cytosolic calcium, reduces F-actin, and promotes albumin diffusion across cultured endothelial monolayers.The Journal of cell biology, 1986
- Protein phosphorylation in cultured endothelial cellsJournal of Cellular Physiology, 1986
- Thrombin‐induced increase in albumin permeability across the endotheliumJournal of Cellular Physiology, 1986
- Forskolin, phosphodiesterase inhibitors, and cyclic AMP analogs inhibit proliferation of cultured bovine aortic endothelial cellsJournal of Cellular Physiology, 1986
- A Method for quantifying F‐Actin in chemotactic peptide activated neutrophils: Study of the effect of tBOC peptideCell Motility, 1985
- Factors controlling the in Vitro growth pattern of human microvascular endothelial cellsJournal of Ultrastructure Research, 1983
- THE ROLE OF β‐KECEPTOR AGONISTS IN THE INHIBITION OF PULMONARY EDEMAAnnals of the New York Academy of Sciences, 1982
- A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissuesLife Sciences, 1976